Articles | EuroIntervention

Clinical research

10.4244/EIJ-D-19-00539 • Dec 6, 2019

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

De Luca G, Damen S, Camaro C, Benit E, Verdoia M, Rasoul S, Liew H, Polad J, Ahmad W, Zambahari R, Postma S, Kedhi E, Suryapranata H

free

Clinical research

10.4244/EIJ-D-19-00463 • Dec 6, 2019

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial

Toth GG, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piróth Z, Fournier S, Piccoli A, van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

free

Clinical research

10.4244/EIJ-D-18-01214 • Dec 6, 2019

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Ruiz Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

free

Clinical research

10.4244/EIJ-D-19-00034 • Dec 6, 2019

Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction

Song P, Hahn J, Gwon H, Jeon K, Yu C, Rha S, Yoon C, Jeong MH

free

Short report

10.4244/EIJ-D-19-00503 • Dec 6, 2019

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Jensen L, Christiansen E, Kristensen SD, Lassen JF, Thuesen L, Bøtker H, Maeng M

free

Image – Interventional flashlight

10.4244/EIJ-D-19-00175 • Dec 6, 2019

Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention

Azzalini L, Bellini B, Montorfano M, Carlino M

free

10.4244/EIJV15I10A154 • Nov 15, 2019

2019 – A leap year for valvular heart disease

Tamburino C, Piazza N, Baumbach A, Windecker S, Maisano F, Prendergast B

free

10.4244/EIJV15I10A155 • Nov 15, 2019

Heart Team 2.0

Reardon MJ, Leon MB, Popma J, Mack MJ

free

10.4244/EIJV15I10A156 • Nov 15, 2019

Eyes of the Heart Team – the interventional imaging specialist: a pathway for future generations

Piazza N, Delgado V, Mylotte D, Hamm C

free

10.4244/EIJV15I10A157 • Nov 15, 2019

Valvular heart disease: when does surgery remain the best option?

Overtchouk P, Vahanian A, Modine T

free

10.4244/EIJV15I10A158 • Nov 15, 2019

The five Ws of transcatheter mitral valve repair: Who, What, When, Where, and Why

Stone GW, Alfieri O

free

10.4244/EIJV15I10A159 • Nov 15, 2019

The five Ws of transcatheter tricuspid valve repair: Who, What, When, Where, and Why

Williams A, Bolling S, Latib A

free

10.4244/EIJV15I10A160 • Nov 15, 2019

Durability of transcatheter bioprosthetic aortic valves: the story so far

Capodanno D, Søndergaard L, Tamburino C

free

Expert review

10.4244/EIJ-D-19-00818 • Nov 15, 2019

Evolving paradigms in valvular heart disease: where should guidelines move?

Baumbach A, Dudek D, Baumgartner H, Windecker S, Haude M

free

Expert review

10.4244/EIJ-D-19-00788 • Nov 15, 2019

Residual challenges in TAVI: moving forward

Barbanti M, Webb JG, Dvir D, Prendergast B

free